AEXA

American Exceptionalism Acquisition A
$11.38
+$0.03 (+0.26%)Sep 10, 2026
2.7FairMoatMint rating

MoatMint rates American Exceptionalism Acquisition A (AEXA) 2.7 out of 10, a research rating of the company's quality, value, growth, momentum and financial health. Its quality rating is 1.1 out of 10.

Key metrics

The numbers that frame AEXA today
Market cap
$562.86M
P/E (TTM)
-384.6
EV / FCF
-772.4
ROIC
-0.4%
Div yield
0%

AEXA stock rating

How AEXA scores on quality, value, growth, momentum and financial health
2.7out of 10
Fair overallNeutral business, full price
Quality1.1
Growth-
Momentum-
Value4.1
Financial Health5.0

Growth

Revenue and earnings trend for AEXA
RevenueNet income
See the full growth breakdown

Revenue and earnings trends, margins and the multi-year trajectory - free with an account.

Create a free account
Free foreverNo card required
Already a member? Log in

Cash flow & returns

Free cash flow and financial health
Free cash flowNet debt
See the full cash-flow picture

Free cash flow detail, returns on capital and the balance-sheet trend - free with an account.

Create a free account
Free foreverNo card required
Already a member? Log in

Insider trading

Recent insider buying and selling activity
PurchasesSales
Unlock every insider trade

See who is buying and selling, how much, and when - updated as new filings land.

Create a free account
Free foreverNo card required
Already a member? Log in

Frequently asked questions

Plain-English answers about AEXA
Is American Exceptionalism Acquisition A a good buy?
No. American Exceptionalism Acquisition A has poor quality. We think American Exceptionalism Acquisition A is selling at a high price.
What is the market capitalization of AEXA?
American Exceptionalism Acquisition A's market capitalization is $562.86M.
What is the P/E ratio for AEXA stock?
American Exceptionalism Acquisition A's current P/E ratio is -384.6.
Does AEXA stock pay dividends?
American Exceptionalism Acquisition A does not currently show a dividend per share in the company data.